Govind Warrier is an Oncology physician affiliated with Bloomberg. OpenAlex indexes 43 publications with 486 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
201 N Broadway St
Baltimore, MD 212870031
Telephone
410-955-8964Provider last certified this registry record 28 Jun 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
64.9%Potassium supplement35.1%Potassium Chloride100%Part D<11 patientsProton pump inhibitor29.7%Pantoprazole Sodium100%Part D<11 patientsCancer & immunology
35.1%Kinase inhibitor35.1%Tagrisso100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Scaling digital patient navigation to improve access to multidisciplinary melanoma care.
Journal of Clinical Oncology
2026 - Understanding Inequalities in Mobile Health Utilization Across Phases: Systematic Review and Meta-Analysis
Journal of Medical Internet Research
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Arturo Casadevall, MD
Bloomberg
Elizabeth Jaffee, MD
Bloomberg
Daniel Laheru, MD
Bloomberg
William Sharfman, MD
Bloomberg
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”